Cesium
Alkalizing-Mineral-Therapy

Cesium is especially important for people with large tumors as a way of rapidly shrinking masses of cancer cells. Supplementation should ideally be carefully monitored by a competent health practitioner. (H.E. Sartori, M.D., Cancer 1985 - Orwellian or Utopian)

Complementary: Enzymes, parasite cleanse, mineral supplementation and emotional work.

2) Introduction to High pH Therapy
3) The Mechanism of Carcinogenesis
4)
B) Low pH Therapy
B) High pH Therapy
C) Tests of High pH Therapy on Mice and Humans
5) The Cancer Personality
6) Geopathogenic Zones
7) Low Incidence Cancer Areas

Cesium & Cancer

In the 1930'a Dr. Otto Warburg won a Nobel Prize for his research on the terrain of cancer cells. A normal cell changes adversely with oxygen deficiency. In this state of hypoxia the cell reverts to fermentation of glucose instead of aerobic oxidation. Lactic acid, the end product of fermentation lowers the pH of the cytoplasm and impairs the ability of DNA and RNA to control cell division, which must increase to hold the lactic acid sludge. Lactic acid also causes pain and impairs enzyme functions. Cancer often appears as a rapidly growing outer cell mass with a core of dead cells.

Cesium is a highly alkaline mineral which limits cellular uptake of glucose, starving cancer cells and decreasing fermentation of lactic acid. Cesium raises intracellular pH to about 8.0 neutralizing the weak organic acid, lactic acid which stops the pain within 12 to 24 hours. A pH of 8.0 is deadly to cancer cells which die off within a few days and are absorbed and eliminated through the kidneys.

Mass spectrographic and isotope studies show that tumor cells prefer uptake of certain alkaline minerals:

• Cesium
• Germanium
• Potassium
• Rubidium

This uptake is enhanced by certain antioxidants:

• Vitamin A
• Vitamin C
• Selenium
• Zinc

In regions where there is high Cesium in the soil cancer is virtually unknown:

• Hopi Indians of Arizona
• Hunza of North Pakistan
• Indians of Central and South America.

Possible side effects of high doses of Cesium:

• Numbness between the mouth and nose
• Nausea
• Flu-like symptoms of cleansing
• Hypotension/arhythmia due to Hypokalemia (those taking high doses of cesium should take additional potassium and/or consume potassium rich vegetables)

High pH Therapy

Tests on mice given cesium and rubidium showed marked shrinkage of tumors within 2 weeks. The mice showed no side effects from the treatment or cancer cell necrosis. Human clinical trials consistently showed tumor shrinkage and resorption. Diet in regions where cancer incidence is lowest is essentially high pH therapy.

High pH therapy for cancer developed from experiments on isotope movement across membranes:

• plant
• animal
• embryo
• cancer cells
• synthetic membranes
• mass spectrographic analyses of membranes and cells
• fluorescence decay studies of many types of cells and organelles

Carcinogenesis-Mechanism

Cations smaller than potassium are taken up sparingly, if at all, by cancer cells. The amount of calcium in cancer cells is about 1% that of normal cells. Potassium transports glucose into the cell while calcium transports oxygen. Thus glucose can easily enter cancer cells with Potassium, but Calcium and Oxygen cannot. This fits the anaerobic state of cancer cells found in the early 1920's by Dr. Otto Warburg.

The similarity in the isotope effect for potassium, cesium and rubidium in cancer and embryonic cells and for the marked difference for calcium was investigated with mass spectrographic analyses, as well as fluorescence and phosphorescence decay patterns. M. Von Ardenne of Dresden, Germany, also studied cellular pH.

Nuclear bio-physicist A. Keith Brewer, PhD. outlines the 4 steps of carcinogenesis:

1. Disturbance of the cell membrane by carcinogens, energy disturbance and parasites: carcinogenic molecules attach to the membrane surface, disturbing activation of P=O (phosphorus double bond oxygen) radicals necessary for transport of oxygen by calcium ions. Carcinogens (mostly polycyclic toxins) interact with irritation of the membrane. When carcinogens attach to the membrane, glucose can enter but oxygen cannot, so the cell becomes anaerobic. The cell membrane can be disturbed by radiation (x-rays, alpha-, beta-, or gamma-rays, UV and EMF). This disturbance interferes with the excitability of P=O and prevents oxygen from entering the cell, though glucose, K, Rb and Cs may still enter. Emotional stresses also cause oxidative damage of the cell membrane from free radicals. These are the primary instigators of cancer and degenerative disease, allergy, auto-immune disease, multiple sclerosis, rheumatoid disease, immune suppression syndromes, most endocrine disease, including diabetes, hypothyroidism, and adrenal insufficiency, and others.
2. Intracellular acidosis from fermentation of glucose to lactic acid in the absence of oxygen. This causes cellular pH to drop from 7.3-7.2 down toward 6.5 and in more advanced stages of cancer and metastasis to 6.0 or even 5.7.
3. DNA, RNA and amino acids in cancer cells lose positive and negative radical sequencing due to the acidic terrain.
4. The control mechanisms dysregulate and cancer spreads in an acidic terrain as cell enzymes change structure and function. Chromosomal aberrations may also occur as an effect of the cancer terrain.

Von Ardenne shows that lysosomal enzymes become very toxic, killing the cells in the center of the tumor. A tumor consists of a thin layer of rapidly growing cells surrounding the dead mass.

High versus Low pH Therapy

Low pH therapy of Von Ardenne and high pH therapy of Brewer are both effective against cancer in laboratory animals and humans.

Low pH Therapy (for comparison only)

Potassium and insulin are injected. Potassium transports glucose into the cells facilitated by the insulin. In cancer cells, the glucose ferments to lactic acid because calcium is unable to transport oxygen across the cancer cell membrane, thus the cancer cell pH drops to 4.5 to 5.5 enhanced by hyperthermia. (43 degrees C = 106 degrees F) for 1 to 6 hours. Diathermy is applied to the tumor so the temperature of the mass risees over 45 degrees C (109 degrees F). At these temperatures cancer cells live a very short life. The problem is that severe toxemia can result from leakage of lactic acidic and toxins from the tumor.

High pH Therapy

Rapid uptake of cesium, rubidium and to a lesser extent Germanium by cancer cells has been used as a therapy (Brewer, 1977) with:

• CsCl (Cesium Chloride) or Cs2CO3 (Cesium Carbonate)
• Vitamin C (ascorbic acid)
• Vitamin A (retinoic acid)
• Zinc
• Selenium

Weak acids absorbed by tumor cells enhance the negative potential gradient across the membrane. Zinc and selenium absorbed on the membrane surface act as broad and moderately strong electron donors (antioxidants). These acids and minerals have been shown in mice to dramatically increase the uptake of cesium and rubidium ions. People with cancer take 6 to 9 gms of CsCl or Cs2CO3 for several days with good tolerance as they raise the pH in tumor cells to at least 8 where malignant cells die in hours or days. Cesium and rubidium also neutralize acidic and toxic material leaking from the tumor. Increased alkalinity also slows the aging process. Dr. A. Keith Brewer, PhD. started taking CsCl at age 87 and at 92 is much more vigorous than when he started.

Tests of High pH Therapy with Mice & Men

American University: Mice

High pH therapy was first tested on mice at American University in Washington, D.C. 2 mm cubes of mammary tumors were implanted in the abdomen of mice and allowed to grow for 8 days. Mice were put in two groups. In addition to a normal diet, the test group was given oral supplementation of 1.11 mg. of rubidium carbonate in an aqueous solution. 13 days later, all mice were sacrificed and the tumors removed and weighed. The tumors in the test animals weighed only 9% of those in the controls. Test animals showed no adverse affects associated with most cancer treatments or cancer itself and no side effects from decaying tumor cells.

University of Wisconsin, Platteville: Mice

Similar results were obtained at the University of Wisconsin-Platteville with intra-peritoneal injection of cesium carbonate, vitamin A and zinc gluconate in mice with subcutaneous implants of colon carcinoma. 97% repression of tumor growth was observed (unpublished).

Texas Tech University: Mice

Intra-peritoneal injections of cesium chloride at Texas University, School of Medicine in Lubbock showed significant shrinkage of tumor masses in 98% of mice.

Human-Clinical-Trials:

Many clinical trials on cancer patients by Dr. Hans Nieper in Germany and doctors in America have been successful. Cancer pain frequently disappears within two days. Tumor masses shrink rapidly.

In most cases, 2 to 3 gms of CsCl were taken orally three times a day after meals. Supportive supplementation of about 5 to 50 gms of vitamin C, 100,000 to 300,000 units of vitamin A, 50 to 100 mgs of zinc, and 200 to 600 mcgs of selenium were also taken.
Two side effects have been observed in some patients: nausea and diarrhea. Dr. Nieper claims the nausea can be relieved by giving cesium in a sorbitol solution.

Balancing of the Cesium-Therapy

In the first 2 weeks there is an initial dramatic reduction of the tumor size and a tremendous improvement of the general well-being especially of dying, moribund or comatose patients. Thereafter, Dr. Sartori often sees slower progress. In this case, the Cs or Rb dosage as well as vitamins A, B6 or D must be stopped for a short time. Instead, they take vitamins E, B1, B2 and K, plus what Dr. Revici gives for an "off-balance D" (dysoxybiosis) or alkaline-catabolic pattern:

• lactic acid for pre-terminal and terminal cancer (organ and organism level)
• butanol and glycerol for painful cancer
• hetanol for the cellular level (invasive cancer).

Monitoring urine pH and potassium levels could suggest a decrease of cesium dosage when urine pH rises above 7.0.

A mild paresthesia (numbness) around the mouth also indicates the therapeutic dose is achieved.

When the specific gravity of the urine goes below 1.015, the urine pH is 6.5 or above, total blood potassium (K) is 40 or above, (or 85 or above for RBC-K), there is an anabolic off-balance and the full dose of Cs or Rb and adjunctive nutrients can be resumed.

You can eat a generous amount of yogurt or sauerkraut or sauerkraut juice if lactic acid is indicated. One patient took 30 ounces of yogurt and by the next morning all his symptoms were gone and he could continue the cesium.

Butanol and Heptanol are effective in controlling the alkaline pattern pain in people with the off-balance D pattern. Butanol is a powerful anti-fibrinolytic agent especially useful for severe arterial hemorrhages. For oozing capillary, venous, and small arterial hemorrhages, fatty acids from cod liver oil are the treatment of choice.

These daily amounts are usually divided into 3 doses:

• Cesium chloride 6 to 9 grams
• Vitamin A-Emulsion 100,000 to 300,000 U
• Vitamin C 4 to 30 grams
• Zinc 60 to 100 mg
• Selenium 60 to 1200 mcg
• Amygdalin 1500 to 3000 mg

Diet is mainly whole grains, locally grown vegetables, linolenic acid-rich oils (linseed, walnut, soy, wheat germ) and a few supplemental foods.

Circulation, oxygenation and treatment efficiency can be enhanced with EDTA, DMSA, DMSO (or MSM), vitamins, potassium and magnesium.

The Cancer Personality

Lawrence LeShan, PhD. reports that 96% of people with cancer have the same type of personality, which must change for permanent success.

Geopathogenic Zones

In the 1930's, the world-famous German surgeon Prof. Dr. Med. Ferdinand Sauerbruch told all his cancer patients never to return to their beds. For centuries, it is known that certain houses have a much higher incidence of cancer, arthritis, multiple sclerosis and other degenerative diseases.

In the early 1970's Geo-pathogenic zones were identified as the cause. These may be caused by a conversion of the gravity field energy from radioactive radiation, electromagnetic phenomena near subterranean streams, high power lines, and color TV's. Geopathological zones can be detected by a dowser or Biofield Analysis.

In Germany it is medical malpractice if a cancer patient is not advised to evaluate his house and workplace, since 93% of cancer victims sleep in Geopathogenic zones. Only if the patient is removed from this zone does he/she have a good chance of permanent recovery in conjunction with diet, lifestyle, appropriate supplementation/medication and psychological modifications.

Low Incidence Cancer Areas

There are a number of areas of the world where the incidence of cancer is very low. The 1978 Stockholm Conference on Food and Cancer concluded that in every case, the Cesium and Rubidium content is very high and the diet is high in vitamin C, vitamin A, Zinc and Selenium.

Summary

High pH therapy for cancer was determined theoretically from an extensive series of physical experiments carried out on cancer cells. Tests have also been carried out on both mice and humans and have shown the therapy to be effective. In these tests, the presence of cesium and rubidium salts in the adjacent fluids were believed to oxygenate the cell and raise the pH of the cancer cell to a higher pH value where cell mitosis ceased and the life of the cell was short. In addition, these salts could neutralize the acidic and toxic material normally formed in cancer cells.

The observation that the incidences of cancer are very low in areas where the cesium and rubidium content of the food intake are high has led to an investigation of the quantity of cesium that would be required to prevent cancer. This dosage seems to be equivalent to 0.5 to 1.0 grams per day of either cesium or rubidium chloride. The therapeutic dose of cesium chloride or rubidium chloride for human adults is between 6 and 9 grams or 100 to 150 mg/kg for children. A mild paresthesia (numbness) around the mouth indicates that this therapeutic dose has been reached.

Cancer cells have an abnormally low pH level (acidosis). The low pH results in the activation of enzymes, e.g. of oncogenic phosphatases, which increase malignant potential and aggressiveness of the cancer cell. The concept to inactivate H+ ions inside the tumor cells is therefore an elegant one.
The eminent American physicist, A. Keith Brewer, PhD., found that cesium and rubidium are taken up by tumor cells and this leads to an increase of the tumor cell pH. These elements inactivate ionic hydrogen and reactivate oxygenation.
The researchers Messiha and El Domeiri at the Texas Tech University Medical School at Lubbock have shown that cesium is most effective in the suppression and regression of Sarcoma-I in mice.

The German scientist Hans Nieper has in the meantime shown that cesium chloride is effective in the management of most problematic tumors, e.g. of advanced brochogenic carcinoma with bone metastization. For this kind of cancer, cesium seems to be the treatment of choice, even with relatively minor changes in lifestyle.

The prevention and treatment of cancer by cesium is a very pragmatic and intelligent one. It is inexpensive and non-toxic over unlimited time.

The application of pure urea, sulfurpeptide and Glutathione for the treatment of cancer seems to have functional similarity to the cesium therapy.

Balancing the high pH therapy using concepts of E. Rivici helps maintain the effectiveness of the treatment in cases were a plateau of the cesium chloride effect is reached.

For maximum effectiveness and lasting success of any metabolic nutritional cancer therapy it is absolutely necessary to affect significant changes in diet, lifestyle and habitat.

This therapy is most effective combined with the patient's compliance with diet, supplementation and lifestyle changes and willingness and ability to make necessary psychological adjustments, and if necessary, change living quarters and work place.

The problem is not so much just getting rid of cancer, but taking responsibility for health, working with the health practitioner and maintaining changes in diet and lifestyle for life. Otherwise, almost inexorably, another degenerative disease, if not cancer, comes up and shortens the lifespan.

References:

1. Brewer, A. K. The mechanism of carcinogenesis: Comments on therapy. J Int Acad Prev Med 5: 29-53, 1979.
2. Brewer, A. K. Cancer: Comments on the physics involved. Am Lab 5: 12-23. 1973.
3. Brewer, A. K., B. J. Clarke, M. Greenberg and N. Rothkopf. The effects of rubidium on mammary tumor growth in C57BL K/6J mice. Cytobios 24: 99-101, 1979.
4. Brewer, A. K. and R. Passwater. Physics of the cell membrane. I. The role of the double bond energy states. Am Lab 6: 59-72, 1974,
5. Brewer, A. K. and R. Passwater. Physics of the cell membrane. II. Fluorescence and phosphorescence in cell analysis. Am Lab 6: 19-29, 1974.
6. Brewer, A. K. and R. Passwater. Physics of the cell membrane. III. The mechanism of nerve action. Am Lab 6: 49-62, 1974.
7. Brewer, A. K. and R. Passwater. Physics of the cell membrane. IV. Further comments on the role of the double-bond. Am Lab 7: 41-50, 1975.
8. Brewer, A. K. and R. Passwater. Physics of the cell membrane. V. Mechanisms involved in cancer. Am Lab 8: 37-45, 1976.
9. Brewer, J. Isotopes of potassium. Ind Chem Eng 30: 893, 1938.
10. Brewer, J. Abundance of the isotopes of potassium in mineral and plant sources. J Am Chem Soc 58: 365-369, 1936.
11. Brewer, A. K. Man spectrographic analysis of the constancy of the atomic weight of potassium in ocean water. J Am Chem Soc 58: 370-375, 1936.
12. Brewer, A. K. Excitation of the hydrocarbon double bond. Am Sci 56: 259, 1968.
13. Brewer, A. K., S. Adelman, H. Hoerman and W. Sanborn. Differential identification of biological entities by phosphorescence decay. Nature 213: 718-719, 1976.
14. Brewer, A. K. and S. Adelman. Method for analysis and identification of biological entities by phosphorescence decay. U.S. Patent 3, 470, 373, 1969.
15. Brewer, A. K. Methods and means for the detection of microorganisms in the air. U.S. Patent 3, 566, 114, 1970.
16. Brewer, A. K. Chemical action in low volt arc. Physiol Rev 42: 785, 1932.
17. Calloway, D. R., R. D. Giaque and F. N. Costa. The superior mineral content of some American Indian food, in comparison to Federal donated counterpart commodities. Ecol Food Nutr 3: 203-210, 1974.
18. Editorial. Lancet 1: 1204, 1964.
19. Masco. H. L. U.S. Patent 3, 614, 242, 1972.
20. Messiha, F. S. The antidepressant action of cesium chloride and ethanol preference in rodents. In: Alcoholism: A Perspective. edited by F. S. Messiha and B. S. Tyner. New York: PJD Pub., 1980, pp. 247-259.
21. Messiha, F. S., A. El-Domeiri and H. F. Sproat. Effects of lithium and cesium salts on sarcoma-I implants in the mouse. Neurobehav Toxicol 1: 27-31, 1979.
22. Special report. Food and cancer. Nutr Rev 36: 313-314, 1978.
23. Von Ardenne M., P. G. Reitnauer and D. Schmidt. Theoretische Grundlagen und in vivo Messungen zur Optimierung der selekiven übersäurung von Krebsgewebe. Acta Biol Med Germ 22: 35-60, 1969.
24. Von Ardenne, M. Selective multiphase cancer therapy: Conceptual aspects and experimental basis. Adv Pharmacol Chemother 10: 339-380, 1972.
25. Von Ardenne, M. and A. Von Ardenne. Berechnung des pH-Profile im Interkapillarraum der Krebsgewebe für die Faelle mit und ohne Langzeit-Glucose- Infusion. Res Exp Med 171: 177-189, 1977.
26. Von Warburg, O. Metabolism of human tumor cells. Klin Wohnschr 4: 2396-2397, 1925.

Information:

• http://www.cancer-coverup.com/story/default.html